Aspen Aerogels price target lowered to $4 from $6 at Barclays

Barclays lowered the firm’s price target on Aspen Aerogels (ASPN) to $4 from $6 and keeps an Underweight rating on the shares. The company reported a “tough” quarter with a substantial guide-down to full year numbers following General Motors’ decision to cut production of electric vehicles, the analyst tells investors in a research note.